Performance Evaluation of AFIAS ST2 and Ichroma ST2 Assays in Comparison with Presage ST2 Assay

Performance Evaluation of AFIAS ST2 and Ichroma ST2 Assays in Comparison with Presage ST2 Assay

Background: Elevated soluble suppression of tumorigenicity 2 (sST2) levels may predict mortality in heart failure (HF) patients. The AFIAS ST2 assay (AFIAS ST2, Boditech Med Inc., Chuncheon, Korea) and ichroma ST2 assay (ichroma ST2, Boditech Med Inc.) are newly developed point-of-care (POC) assays...

Full description

Bibliographic Details
Main Authors: Hanah Kim, Tae-Hwan Lee, Mina Hur, Hyun-Joong Kim, Hyun Suk Yang, Kyeong Ryong Lee, Salvatore Di Somma
Format: Article
Language:English
Published: IMR Press 2023-03-01
Series:Reviews in Cardiovascular Medicine
Subjects:
soluble suppression of tumorigenicity 2
point-of-care
performance
cut-off
comparison
prognosis
heart failure
Online Access:https://www.imrpress.com/journal/RCM/24/4/10.31083/j.rcm2404100

Internet

https://www.imrpress.com/journal/RCM/24/4/10.31083/j.rcm2404100

Similar Items